Brokerage firms like UBS have a neutral rating on Bharti Airtel, while Nomura has buy ratings on Macrotech Developers and BPCL. Additionally, Nuvama and Jefferies hold buy ratings on Federal Bank and Sun Pharma, respectively. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: UBS on Bharti Airtel: … Read more
Indian headline indices ended in the red on Saturday conceding their morning gains amid selling pressure in FMCG, IT and pharma sectors despite a good show by banks. The S&P BSE Sensex declined nearly 260 points while the Nifty50 closed below 21,600 level. Stocks that were in focus include names like Bharti Airtel rose more … Read more
Bharti Airtel, part of the telecom space, bounced back after retesting its crucial support, placed near Rs 640 levels for the fourth time so far in 2022. Short-term traders can look to capture the trend and buy now for a target of Rs 770, closer to its 52-week high of Rs 781 recorded on 24 … Read more
NEW DELHI: Notwithstanding Dalal Street’s muted reaction to ’s March quarter numbers, analysts said the telecom operator’s numbers were largely in line, and that they liked the steady Ebitda sans any tariff hike, besides addition of quality 4G subscribers, superior network capacity and the growth in home business. While earnings estimates for the telecom operator … Read more
The country’s second largest telco, Bharti Airtel, on Thursday bought an additional 4.9 per cent stake in its tower arm Bharti Infratel via open market block deals, paying anywhere between Rs 3,150-3,300 crore, sources said. In post noon trade, Bharti Infratel stock price was up 2.2 per cent to touch Rs 220.60 on the BSE … Read more